NYSE: HQL - Tekla Life Sciences Investors

Altı ay boyunca karlılık: -14.59%
Temettü getirisi: +12.12%
Sektör: Financials

Promosyon programı Tekla Life Sciences Investors

Gelişmiş program Basit grafik
Financial Markets by TradingView

Şirket hakkında Tekla Life Sciences Investors

Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies.

daha fazla ayrıntı
It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. It was formerly known as H&Q Life Sciences Investors fund. Tekla Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.
Karşılaştırma listesine ekle
İzleme listesine ekle
Portföye ekle
Fiyat bildirimi ekle

IPO date 1992-05-04
ISIN US87911K1007
Industry Capital Markets
Sector Financials
Валюта usd
Валюта отчета usd
Див.доход ао 15.06
Дивиденд ао 2.33
Сайт https://www.teklacap.com/hql.html
Цена ао 13.01
Günlük fiyat değişimi: -0.7704% (12.98)
Haftalık fiyat değişimi: -1.98% (13.14)
Aylık fiyat değişimi: -4.1% (13.43)
3 ayda fiyat değişimi: -4.59% (13.5)
Altı ayda fiyat değişimi: -14.59% (15.08)
Yıllık fiyat değişimi: -5.5% (13.63)
3 yılda fiyat değişimi: -21.03% (16.31)
5 yılda fiyat değişimi: -22.97% (16.72)
Yılbaşından bu yana fiyat değişimi: -1.83% (13.12)
Tüm parametreler

Hafife alma

İsim Anlam Seviye
P/S 4.88 3
P/BV 0.9204 9
P/E 4.96 10
EV/EBITDA 14.85 7
Toplam: 8.63

Yeterlik

İsim Anlam Seviye
ROA, % 19.76 6
ROE, % 19.8 6
Toplam: 5.17

Temettüler

İsim Anlam Seviye
Div yield, % 12.12 10
DSI 0.8571 8.57
Toplam: 7.58

Görev

İsim Anlam Seviye
Debt/EBITDA 0 10
Toplam: 10

Büyüme dürtüsü

İsim Anlam Seviye
karlılık Revenue, % -30.15 0
karlılık Ebitda, % -131.71 0
karlılık EPS, % -41.09 0
Toplam: 0
Daha fazla ayrıntı

Daha fazla ayrıntı

Kurumlar Hacim Paylaşmak, %
Saba Capital Management, L.P. 1421300 5.42
Cornerstone Advisors, LLC 494340 1.89
1607 Capital Partners, LLC 480179 1.83
Allspring Global Investments Holdings, LLC 454154 1.73
Morgan Stanley 430266 1.64
AQR Arbitrage LLC 384231 1.47
Clough Capital Partners, LP 375410 1.43
RPO LLC 338542 1.29
Needham Investment Management, L.L.C. 313792 1.2
Flagship Harbor Advisors, LLC 264003 1.01

ETFPaylaşmak, %Yıllık karlılık, %Temettüler, %
Saba Closed End Funds ETF 2.8917 17.31 2.29022
Amplify High Income ETF 2.263 6.94 2.77149
First Trust Income Opportunities ETF 0.4681 18.3 2.48805
1.8714.182.52



Süpervizör İş unvanı Ödeme Doğum yılı
Dr. Daniel R. Omstead M.S, Ph.D. Principal Executive Officer, President and Trustee N/A 1953 (72 yıl)
Mr. Peter Branner Chief Investment Officer N/A 1964 (61 yıl)

Adres: United States, Boston. MA, 100 Federal Street - Google haritalarda aç, Yandex haritalarını aç
Web sitesi: https://www.teklacap.com/hql.html